Atara biotherapeutics names biopharmaceutical executive charlene banard as chief technical officer

South san francisco, calif.--(business wire)--atara biotherapeutics, inc. (nasdaq: atra), a leader in t-cell immunotherapy, leveraging its novel allogeneic ebv t-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announces biopharmaceutical executive charlene banard will join as chief technical officer. charlene will oversee process science and development, quality, manufacturing, and supply. “bringing a seasoned leader like charlene to ata
ATRA Ratings Summary
ATRA Quant Ranking